LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 51

Search options

  1. Article ; Online: The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease.

    Balogun, Oluwashanu / Nejak-Bowen, Kari

    Seminars in liver disease

    2023  Volume 43, Issue 4, Page(s) 446–459

    Abstract: The porphyrias are a group of metabolic disorders that are caused by defects in heme biosynthesis pathway enzymes. The result is accumulation of heme precursors, which can cause neurovisceral and/or cutaneous photosensitivity. Liver is commonly either a ... ...

    Abstract The porphyrias are a group of metabolic disorders that are caused by defects in heme biosynthesis pathway enzymes. The result is accumulation of heme precursors, which can cause neurovisceral and/or cutaneous photosensitivity. Liver is commonly either a source or target of excess porphyrins, and porphyria-associated hepatic dysfunction ranges from minor abnormalities to liver failure. In this review, the first of a three-part series, we describe the defects commonly found in each of the eight enzymes involved in heme biosynthesis. We also discuss the pathophysiology of the hepatic porphyrias in detail, covering epidemiology, histopathology, diagnosis, and complications. Cellular consequences of porphyrin accumulation are discussed, with an emphasis on oxidative stress, protein aggregation, hepatocellular cancer, and endothelial dysfunction. Finally, we review current therapies to treat and manage symptoms of hepatic porphyria.
    MeSH term(s) Humans ; Rare Diseases/complications ; Porphyrins/metabolism ; Porphyrias/diagnosis ; Porphyrias/therapy ; Porphyrias/complications ; Porphyrias, Hepatic/epidemiology ; Porphyrias, Hepatic/therapy ; Porphyrias, Hepatic/complications ; Heme/metabolism ; Liver Neoplasms/metabolism
    Chemical Substances Porphyrins ; Heme (42VZT0U6YR)
    Language English
    Publishing date 2023-11-16
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 603177-8
    ISSN 1098-8971 ; 0272-8087
    ISSN (online) 1098-8971
    ISSN 0272-8087
    DOI 10.1055/s-0043-1776760
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Wnt-β-catenin in hepatobiliary homeostasis, injury, and repair.

    Nejak-Bowen, Kari / Monga, Satdarshan P

    Hepatology (Baltimore, Md.)

    2023  Volume 78, Issue 6, Page(s) 1907–1921

    Abstract: Wnt-β-catenin signaling has emerged as an important regulatory pathway in the liver, playing key roles in zonation and mediating contextual hepatobiliary repair after injuries. In this review, we will address the major advances in understanding the role ... ...

    Abstract Wnt-β-catenin signaling has emerged as an important regulatory pathway in the liver, playing key roles in zonation and mediating contextual hepatobiliary repair after injuries. In this review, we will address the major advances in understanding the role of Wnt signaling in hepatic zonation, regeneration, and cholestasis-induced injury. We will also touch on some important unanswered questions and discuss the relevance of modulating the pathway to provide therapies for complex liver pathologies that remain a continued unmet clinical need.
    MeSH term(s) beta Catenin/metabolism ; Liver/pathology ; Wnt Signaling Pathway ; Liver Regeneration ; Homeostasis
    Chemical Substances beta Catenin
    Language English
    Publishing date 2023-05-30
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1097/HEP.0000000000000495
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Correction: Conditional Genetic Elimination of Hepatocyte Growth Factor in Mice Compromises Liver Regeneration after Partial Hepatectomy.

    Nejak-Bowen, Kari / Orr, Anne / Bowen, William C / Michalopoulos, George K

    PloS one

    2023  Volume 18, Issue 2, Page(s) e0282358

    Abstract: This corrects the article DOI: 10.1371/journal.pone.0059836.]. ...

    Abstract [This corrects the article DOI: 10.1371/journal.pone.0059836.].
    Language English
    Publishing date 2023-02-23
    Publishing country United States
    Document type Published Erratum
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0282358
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease

    Balogun, Oluwashanu / Nejak-Bowen, Kari

    Seminars in Liver Disease

    2023  Volume 43, Issue 04, Page(s) 446–459

    Abstract: The porphyrias are a group of metabolic disorders that are caused by defects in heme biosynthesis pathway enzymes. The result is accumulation of heme precursors, which can cause neurovisceral and/or cutaneous photosensitivity. Liver is commonly either a ... ...

    Abstract The porphyrias are a group of metabolic disorders that are caused by defects in heme biosynthesis pathway enzymes. The result is accumulation of heme precursors, which can cause neurovisceral and/or cutaneous photosensitivity. Liver is commonly either a source or target of excess porphyrins, and porphyria-associated hepatic dysfunction ranges from minor abnormalities to liver failure. In this review, the first of a three-part series, we describe the defects commonly found in each of the eight enzymes involved in heme biosynthesis. We also discuss the pathophysiology of the hepatic porphyrias in detail, covering epidemiology, histopathology, diagnosis, and complications. Cellular consequences of porphyrin accumulation are discussed, with an emphasis on oxidative stress, protein aggregation, hepatocellular cancer, and endothelial dysfunction. Finally, we review current therapies to treat and manage symptoms of hepatic porphyria.
    Keywords porphyria ; heme ; δ-aminolevulinic acid ; acute intermittent porphyria ; neurovisceral
    Language English
    Publishing date 2023-11-01
    Publisher Thieme Medical Publishers, Inc.
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 603177-8
    ISSN 1098-8971 ; 0272-8087
    ISSN (online) 1098-8971
    ISSN 0272-8087
    DOI 10.1055/s-0043-1776760
    Database Thieme publisher's database

    More links

    Kategorien

  5. Article ; Online: Ductular Reaction and Liver Regeneration: Fulfilling the Prophecy of Prometheus!

    Monga, Satdarshan P / Nejak-Bowen, Kari

    Cellular and molecular gastroenterology and hepatology

    2022  Volume 15, Issue 3, Page(s) 806–808

    MeSH term(s) Humans ; Liver Regeneration ; Liver/pathology ; Hyperplasia/pathology
    Language English
    Publishing date 2022-11-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 2819778-1
    ISSN 2352-345X ; 2352-345X
    ISSN (online) 2352-345X
    ISSN 2352-345X
    DOI 10.1016/j.jcmgh.2022.11.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: If It Looks Like a Duct and Acts Like a Duct: On the Role of Reprogrammed Hepatocytes in Cholangiopathies.

    Nejak-Bowen, Kari

    Gene expression

    2019  Volume 20, Issue 1, Page(s) 19–23

    Abstract: Cholangiopathies are chronic, progressive diseases of the biliary tree, and can be either acquired or genetic. The primary target is the cholangiocyte (CC), the cell type lining the bile duct that is responsible for bile modification and transport. ... ...

    Abstract Cholangiopathies are chronic, progressive diseases of the biliary tree, and can be either acquired or genetic. The primary target is the cholangiocyte (CC), the cell type lining the bile duct that is responsible for bile modification and transport. Despite advances in our understanding and diagnosis of these diseases in recent years, there are no proven therapeutic treatments for the majority of the cholangiopathies, and liver transplantation is the only life-extending treatment option for patients with end-stage cholestatic liver disease. One potential therapeutic strategy is to facilitate endogenous repair of the biliary system, which may alleviate intrahepatic cholestasis caused by these diseases. During biliary injury, hepatocytes (HC) are known to alter their phenotype and acquire CC-like features, a process known as cellular reprogramming. This brief review discusses the potential ways in which reprogrammed HC may contribute to biliary repair, thereby restoring bile flow and reducing the severity of cholangiopathies. Some of these include modifying bile to reduce toxicity, serving as a source of de novo CC to repair the biliary epithelium, or creating new channels to facilitate bile flow.
    MeSH term(s) Animals ; Bile/metabolism ; Bile Duct Diseases/chemically induced ; Bile Duct Diseases/pathology ; Bile Duct Diseases/therapy ; Bile Ducts, Intrahepatic/cytology ; Bile Ducts, Intrahepatic/pathology ; Cell Transdifferentiation/physiology ; Cellular Reprogramming/physiology ; Cellular Reprogramming Techniques ; Cholestasis, Intrahepatic/metabolism ; Cholestasis, Intrahepatic/pathology ; Disease Models, Animal ; Epithelial Cells/cytology ; Hepatocytes/pathology ; Humans ; Pyridines/toxicity
    Chemical Substances 3,5-diethoxycarbonyl-1,4-dihydrocollidine ; Pyridines
    Language English
    Publishing date 2019-08-22
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural
    ZDB-ID 1151108-4
    ISSN 1555-3884 ; 1052-2116
    ISSN (online) 1555-3884
    ISSN 1052-2116
    DOI 10.3727/105221619X15664105014956
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Role of YAP1 Signaling in Biliary Development, Repair, and Disease.

    Molina, Laura / Nejak-Bowen, Kari / Monga, Satdarshan P

    Seminars in liver disease

    2022  Volume 42, Issue 1, Page(s) 17–33

    Abstract: Yes-associated protein 1 (YAP1) is a transcriptional coactivator that activates transcriptional enhanced associate domain transcription factors upon inactivation of the Hippo signaling pathway, to regulate biological processes like proliferation, ... ...

    Abstract Yes-associated protein 1 (YAP1) is a transcriptional coactivator that activates transcriptional enhanced associate domain transcription factors upon inactivation of the Hippo signaling pathway, to regulate biological processes like proliferation, survival, and differentiation. YAP1 is most prominently expressed in biliary epithelial cells (BECs) in normal adult livers and during development. In the current review, we will discuss the multiple roles of YAP1 in the development and morphogenesis of bile ducts inside and outside the liver, as well as in orchestrating the cholangiocyte repair response to biliary injury. We will review how biliary repair can occur through the process of hepatocyte-to-BEC transdifferentiation and how YAP1 is pertinent to this process. We will also discuss the liver's capacity for metabolic reprogramming as an adaptive mechanism in extreme cholestasis, such as when intrahepatic bile ducts are absent due to YAP1 loss from hepatic progenitors. Finally, we will discuss the roles of YAP1 in the context of pediatric pathologies afflicting bile ducts, such as Alagille syndrome and biliary atresia. In conclusion, we will comprehensively discuss the spatiotemporal roles of YAP1 in biliary development and repair after biliary injury while describing key interactions with other well-known developmental pathways.
    MeSH term(s) Bile Ducts, Intrahepatic/metabolism ; Bile Ducts, Intrahepatic/pathology ; Biliary Tract ; Biological Phenomena ; Child ; Humans ; Liver/metabolism ; Transcription Factors/metabolism ; YAP-Signaling Proteins
    Chemical Substances Transcription Factors ; YAP-Signaling Proteins ; YAP1 protein, human
    Language English
    Publishing date 2022-01-24
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 603177-8
    ISSN 1098-8971 ; 0272-8087
    ISSN (online) 1098-8971
    ISSN 0272-8087
    DOI 10.1055/s-0041-1742277
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Role and Regulation of Wnt/β-Catenin in Hepatic Perivenous Zonation and Physiological Homeostasis.

    Goel, Chhavi / Monga, Satdarshan P / Nejak-Bowen, Kari

    The American journal of pathology

    2021  Volume 192, Issue 1, Page(s) 4–17

    Abstract: Metabolic heterogeneity or functional zonation is a key characteristic of the liver that allows different metabolic pathways to be spatially regulated within the hepatic system and together contribute to whole body homeostasis. These metabolic pathways ... ...

    Abstract Metabolic heterogeneity or functional zonation is a key characteristic of the liver that allows different metabolic pathways to be spatially regulated within the hepatic system and together contribute to whole body homeostasis. These metabolic pathways are segregated along the portocentral axis of the liver lobule into three hepatic zones: periportal, intermediate or midzonal, and perivenous. The liver performs complementary or opposing metabolic functions within different hepatic zones while synergistic functions are regulated by overlapping zones, thereby maintaining the overall physiological stability. The Wnt/β-catenin signaling pathway is well known for its role in liver growth, development, and regeneration. In addition, the Wnt/β-catenin pathway plays a fundamental and dominant role in hepatic zonation and signals to orchestrate various functions of liver metabolism and pathophysiology. The β-catenin protein is the central player in the Wnt/β-catenin signaling cascade, and its activation is crucial for metabolic patterning of the liver. However, dysregulation of Wnt/β-catenin signaling is also implicated in different liver pathologies, including those associated with metabolic syndrome. β-Catenin is preferentially localized in the central region of the hepatic lobule surrounding the central vein and regulates multiple functions of this region. This review outlines the role of Wnt/β-catenin signaling pathway in controlling the different metabolic processes surrounding the central vein and its relation to liver homeostasis and dysfunction.
    Language English
    Publishing date 2021-11-30
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural
    ZDB-ID 2943-9
    ISSN 1525-2191 ; 0002-9440
    ISSN (online) 1525-2191
    ISSN 0002-9440
    DOI 10.1016/j.ajpath.2021.09.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Correction

    Kari Nejak-Bowen / Anne Orr / William C Bowen / George K Michalopoulos

    PLoS ONE, Vol 18, Iss 2, p e

    Conditional Genetic Elimination of Hepatocyte Growth Factor in Mice Compromises Liver Regeneration after Partial Hepatectomy.

    2023  Volume 0282358

    Abstract: This corrects the article DOI:10.1371/journal.pone.0059836.]. ...

    Abstract [This corrects the article DOI:10.1371/journal.pone.0059836.].
    Keywords Medicine ; R ; Science ; Q
    Language English
    Publishing date 2023-01-01T00:00:00Z
    Publisher Public Library of Science (PLoS)
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  10. Article: Role of YAP1 Signaling in Biliary Development, Repair, and Disease

    Molina, Laura / Nejak-Bowen, Kari / Monga, Satdarshan P.

    Seminars in Liver Disease

    2022  Volume 42, Issue 01, Page(s) 17–33

    Abstract: Yes-associated protein 1 (YAP1) is a transcriptional coactivator that activates transcriptional enhanced associate domain transcription factors upon inactivation of the Hippo signaling pathway, to regulate biological processes like proliferation, ... ...

    Abstract Yes-associated protein 1 (YAP1) is a transcriptional coactivator that activates transcriptional enhanced associate domain transcription factors upon inactivation of the Hippo signaling pathway, to regulate biological processes like proliferation, survival, and differentiation. YAP1 is most prominently expressed in biliary epithelial cells (BECs) in normal adult livers and during development. In the current review, we will discuss the multiple roles of YAP1 in the development and morphogenesis of bile ducts inside and outside the liver, as well as in orchestrating the cholangiocyte repair response to biliary injury. We will review how biliary repair can occur through the process of hepatocyte-to-BEC transdifferentiation and how YAP1 is pertinent to this process. We will also discuss the liver's capacity for metabolic reprogramming as an adaptive mechanism in extreme cholestasis, such as when intrahepatic bile ducts are absent due to YAP1 loss from hepatic progenitors. Finally, we will discuss the roles of YAP1 in the context of pediatric pathologies afflicting bile ducts, such as Alagille syndrome and biliary atresia. In conclusion, we will comprehensively discuss the spatiotemporal roles of YAP1 in biliary development and repair after biliary injury while describing key interactions with other well-known developmental pathways.
    Keywords Hippo signaling ; bile duct development ; cholestasis ; transdifferentiation ; ductular reaction
    Language English
    Publishing date 2022-01-24
    Publisher Thieme Medical Publishers, Inc.
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 603177-8
    ISSN 1098-8971 ; 0272-8087
    ISSN (online) 1098-8971
    ISSN 0272-8087
    DOI 10.1055/s-0041-1742277
    Database Thieme publisher's database

    More links

    Kategorien

To top